Sperm DNA Fragmentation
Sperm DNA fragmentation refers to breaks in the genetic material carried inside the sperm head, which a standard semen report cannot see. It is one of the more heavily marketed tests in fertility medicine, and one of the most frequently oversold, so this page is deliberately careful about what the evidence does and does not support. If you have been offered this test, you should understand what it measures, when it genuinely changes a decision, and when it simply adds cost.
What sperm DNA fragmentation is
Each sperm carries a tightly packed copy of half your genetic code. Sperm DNA fragmentation describes single or double-strand breaks in that packed DNA.
Some degree of fragmentation is present in every man’s sample, including men who conceive without difficulty. The question is never whether you have any, but whether you have an unusual amount of it.
A sperm with damaged DNA can still look normal under the microscope and can still swim and fertilise an egg. That is precisely why a seminal fluid analysis cannot detect it, and why the question arises separately.
What the test measures
The laboratory reports a DNA fragmentation index, or DFI: the percentage of sperm in the sample showing DNA damage. A higher percentage means more affected sperm.
The result is a proportion, not a yes or no. It is also a snapshot of one sample on one day, and like other semen parameters it varies between samples from the same man.
Collection conditions affect it. The usual two to seven days of abstinence applies here as elsewhere, and a sample delayed in transit or left in the heat can read higher than the man’s true baseline.
Why the method matters
Several different assays are in use — SCSA, TUNEL, the comet assay and sperm chromatin dispersion tests among them. They measure related but not identical things.
The consequence is practical: the numbers are not interchangeable, and each assay carries its own threshold. A DFI from one laboratory cannot be compared with a DFI from another using a different method, and any clinic quoting a single universal cut-off is oversimplifying.
If you are having the test, ask which assay is being used and what threshold that laboratory applies.
Should the result be repeated?
Like every semen parameter, DNA integrity fluctuates. A single raised result taken during or shortly after an illness, or after an unusually long abstinence interval, may not represent your baseline at all.
If a raised result is going to change your treatment, it is worth confirming on a second sample — and, where a reversible cause has been addressed in the meantime, after an interval of around three months. Acting irreversibly on one number is rarely justified.
What causes it
- Oxidative stress — the common pathway behind most of the causes below.
- Varicocele — dilated scrotal veins, assessed on examination. See varicocele.
- Genital tract infection or inflammation.
- Smoking, heavy alcohol use and obesity.
- Heat exposure — prolonged driving, hot working environments.
- Advanced paternal age.
- Chemotherapy, radiotherapy and some occupational chemical exposures.
- Very long abstinence — a reversible and frequently overlooked contributor.
Counts and DNA integrity are separate measurements, so a man with oligospermia may have normal DNA integrity, and a man with an entirely normal count may not.
Who might reasonably consider testing
There are situations where the result can genuinely influence a plan: recurrent miscarriage, repeated cycles in which embryos developed poorly without another explanation, unexplained infertility after a full assessment of both partners, or a borderline decision about whether to treat a varicocele.
Notice what those situations have in common: in each one, something has already happened that needs explaining. The test is being used to investigate a specific problem, not to screen a man in whom no problem has yet appeared.
Outside those situations, testing a man at the start of a straightforward work-up rarely changes what is done next. That is the honest position, even though it is not the profitable one.
What the test cannot tell you
A high DFI does not mean you cannot father a child, and men with high results do conceive, naturally and with treatment. A normal DFI does not guarantee anything either, and it does not exclude other causes.
The test cannot predict what will happen in your particular cycle. It describes a population-level association, and translating that into an individual prediction is exactly where this kind of testing is most often misrepresented.
Nor does it identify which individual sperm are affected. The assay damages the sperm it examines, so the sperm tested is never the sperm used.
Finally, it does not apportion blame. Fragmentation rises with ordinary exposures that most men have — age, heat, a stretch of heavy drinking, a job involving long hours of driving. A raised number is information about biology, not a verdict on how you have lived.
Where the guidelines stand
The AUA/ASRM guideline on infertility in men advises against routine use of sperm DNA fragmentation testing in the initial evaluation of the infertile male, on the grounds that the evidence does not yet support it as a standard test.
The EAU Guidelines on Sexual and Reproductive Health take a similarly measured view. Neither body forbids the test; both decline to recommend it for everyone, which is a meaningful distinction and the one this page is built on.
What can be done about a high result
The first response is to look for a reversible cause rather than to escalate treatment. Stopping smoking, reducing alcohol, losing excess weight, reducing heat exposure, treating an infection and shortening a long abstinence interval are all reasonable, and all take about three months to show in a repeat sample.
Repairing a significant varicocele may reduce sperm DNA fragmentation in carefully selected men. Antioxidant supplements are widely sold for this purpose, but the evidence that they improve live birth outcomes is weak, and they should be presented to you as uncertain rather than as treatment.
In the laboratory, options include using testicular rather than ejaculated sperm in selected cases, and sperm selection techniques alongside ICSI. PICSI and ICSI are described separately, and sperm aneuploidy testing answers a different question again.
How we decide whether to offer an add-on
At Jananam, laboratory add-ons are offered selectively, where there is a specific reason in your case, rather than routinely to everyone who walks in. Sperm DNA fragmentation testing is treated that way.
That principle is not just a statement. The ERA endometrial receptivity test was used here in more than 750 patients and is no longer offered, because the accumulated evidence did not justify continuing with it. Withdrawing a test you have invested years in is harder than adding one.
You are entitled to ask, of any test offered to you: what will you do differently depending on the result? If there is no clear answer, the test is not yet worth your money.
Your consultation in Chennai
Both partners are evaluated before a plan is made. With recurrent miscarriage or repeated cycles behind you, a sperm DNA fragmentation result is only one input among several, and it is weighed alongside her assessment rather than read in isolation.
Bring previous semen reports, any earlier DFI result with the assay named, and the history of any pregnancies or treatment cycles so far.
It also helps to arrive with a clear question of your own. Whether you are asking why a previous cycle went the way it did, or whether a varicocele should be repaired, naming the question makes it far easier to judge which tests earn their place.
Written and medically reviewed by Dr. Vani Sundarapandian, MD, DGO, FRCOG (UK) — founder and Medical Director, Jananam Fertility Centre, Chennai.
